Table 1.

Replicated studies of risk variants in Parkinson’s disease

Gene	Variant	Population	MAF Affected	MAF Unaffected	OR	PAR%
	REP-1	Caucasian	0.07	0.06	1.2	0.71
	REP-1	Asian	0.33	0.29	1.2	3.07
	rs11931074	Caucasian	0.09	0.07	1.3	1.04
	rs1812923	Caucasian	0.45	0.44	1.04	1.16
		Asian	0.70	0.69	1.01	0.70
	rs2301134	Caucasian	0.50	0.49	1.02	0.58
	rs2583988	Caucasian	0.30	0.27	1.17	2.45
SNCA	rs2619363	Caucasian	0.30	0.28	1.13	1.47
		Asian	0.01	0.00	1.09	0.02
	rs2619364	Caucasian	0.30	0.27	1.16	2.42
	rs2737029	Caucasian	0.45	0.39	1.31	6.42
		Asian	0.68	0.58	1.59	15.16
	rs356165	Caucasian	0.44	0.36	1.42	7.58
		Asian	0.33	0.43	1.51	13.14
	rs356219	Caucasian	0.42	0.36	1.28	6.28
	rs356221	Caucasian	0.49	0.48	1.02	0.61
	rs242557	Caucasian	0.40	0.38	1.11	2.13
		Asian	0.65	0.60	1.23	8.76
MAPT	rs242562	Caucasian	0.38	0.37	1.01	0.28
		Asian	0.43	0.38	1.20	3.76
	rs3785883	Caucasian	0.19	0.18	1.00	0.08
		Asian	0.16	0.14	1.15	1.50
GBA	N370S (A1226G)	Caucasian	0.03	0.02	1.32	0.52

Data downloaded from www.pdgene.com including all studies replicated in at least four independent case-control samples. Odds ratios (OR) and population attributable risk factors (PAR%) were calculated for each variant.